RecruitingPhase 3NCT07226258

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee

Sponsor

Saol Therapeutics Inc

Enrollment

150 participants

Start Date

Nov 7, 2025

Study Type

INTERVENTIONAL

Conditions

Osteoarthritis Knee Pain

Summary

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Normal Saline and a drug called SL1002 for people with osteoarthritis knee pain. The study is currently recruiting participants at 20 locations. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSL1002

SL1002 injectable solution

DRUGNormal Saline

Normal Saline

Locations(21)

Sutter Neurology and Pain Management

Roseville, California, United States

Innovative Pain Treatment Solutions

San Diego, California, United States

DBPS Research, LLC

Greenwood Village, Colorado, United States

International Spine, Pain & Performance Center

Washington D.C., District of Columbia, United States

Prime Medical Research

Coral Gables, Florida, United States

Conquest Research, LLC

Orlando, Florida, United States

Conquest Research, LLC

Winter Park, Florida, United States

Mayo Clinic

Rochester, Minnesota, United States

Queen City Clinical Research, PLLC

Charlotte, North Carolina, United States

The Center for Clinical Research

Winston-Salem, North Carolina, United States

Comprehensive Specialty Care

Edmond, Oklahoma, United States

Pacific Sports and Spine

Eugene, Oregon, United States

University Orthopedics Center

Altoona, Pennsylvania, United States

Pain Diagnostics & Interventional Care LLC

Sewickley, Pennsylvania, United States

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States

PCPMG Clinical Research Unit, LLC

Greenville, South Carolina, United States

Legent Orthopedic and Spine Hospital

Bellaire, Texas, United States

Institute of Precision Pain Medicine

Corpus Christi, Texas, United States

International Spine, Pain & Performance Center (IPP)

Tyler, Texas, United States

University of Utah Orthopedic Center

Salt Lake City, Utah, United States

Virginia iSpine Physicians, PC

Richmond, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07226258

Related Trials

Revised Targets for Knee Radiofrequency Ablation

NCT069344212 locations